Orgenesis (ORGS)
(Delayed Data from NSDQ)
$0.51 USD
0.00 (0.62%)
Updated Apr 26, 2024 03:57 PM ET
After-Market: $0.51 0.00 (0.57%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Orgenesis Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 36 | 36 | 8 | 33 |
Cost Of Goods | 6 | 27 | 37 | 84 | 18 |
Gross Profit | -6 | 9 | -1 | -76 | 15 |
Selling & Adminstrative & Depr. & Amort Expenses | 48 | 18 | 13 | 19 | 40 |
Income After Depreciation & Amortization | -54 | -9 | -15 | -96 | -25 |
Non-Operating Income | -8 | -1 | -2 | 0 | 0 |
Interest Expense | 3 | 2 | 1 | 1 | 1 |
Pretax Income | -64 | -12 | -18 | -97 | -25 |
Income Taxes | 0 | 0 | 0 | -2 | 1 |
Minority Interest | -10 | 3 | 0 | -1 | 2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -65 | -12 | -18 | -95 | -26 |
Extras & Discontinued Operations | 0 | 0 | 0 | 96 | 0 |
Net Income (GAAP) | -55 | -15 | -18 | 1 | -28 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -52 | -7 | -13 | -94 | -21 |
Depreciation & Amortization (Cash Flow) | 2 | 2 | 2 | 1 | 4 |
Income After Depreciation & Amortization | -54 | -9 | -15 | -96 | -25 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 29.01 | 25.10 | 24.27 | 21.32 | 15.91 |
Diluted EPS Before Non-Recurring Items | -1.91 | -0.59 | -0.74 | -4.46 | -1.77 |
Diluted Net EPS (GAAP) | -1.91 | -0.59 | 0.74 | 0.29 | -1.77 |
Fiscal Year end for Orgenesis Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | -13.60 | 0.11 | 6.98 | 7.04 |
Cost Of Goods | NA | -0.65 | 0.95 | 3.23 | 2.72 |
Gross Profit | NA | -12.95 | -0.84 | 3.74 | 4.32 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 22.40 | 10.91 | 7.08 | 7.53 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -35.35 | -11.75 | -3.34 | -3.21 |
Non-Operating Income | NA | -8.44 | 0.00 | 0.41 | -0.28 |
Interest Expense | NA | 0.69 | 0.51 | 0.66 | 0.64 |
Pretax Income | NA | -44.48 | -12.26 | -3.57 | -4.13 |
Income Taxes | NA | -0.14 | 0.39 | 0.09 | 0.13 |
Minority Interest | NA | -9.95 | 0.00 | 0.47 | -0.07 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -44.34 | -12.65 | -3.66 | -4.26 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -34.39 | -12.65 | -4.13 | -4.19 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 29.16 | 28.36 | 26.25 |
Diluted EPS Before Non-Recurring Items | -99,999.00 | -99,999.00 | -0.43 | -0.15 | -0.17 |
Diluted Net EPS (GAAP) | -99,999.00 | -1.17 | -0.43 | -0.15 | -0.16 |